Evidence map›Paper›PMID 42298802›Full record

ArticleJournal of applied clinical medical physics2026

A dosimetric analysis of a rotating gamma ray system and volumetric modulated arc therapy in retrospective replanning for primary liver cancer.

Jiarui Zhang, Siming Shi, Jingran Wu, Lei Shi, Liying Song, Meng Yang, Huiyang Yu, Peng Zhen, Fang Fang

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiarui ZhangDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.ORCID https://orcid.org/0009-0004-0459-6267
Siming ShiDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Jingran WuDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Lei ShiDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Liying SongDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Meng YangDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Huiyang YuDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Peng ZhenDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.
Fang FangDepartment of Radiation Oncology, Chifeng Tumor Hospital, Inner Mongolia Autonomous Region, Chifeng, China.

Funding

2025 Special Research Project on Tumor Immunity and Targeted TherapyChifeng Natural Science Research Project 2024-184Wu Jieping Medical Foundation 320.6750.2025-06-215
6 · The paper itself

Abstract

backgroundThis study is a retrospective replanning study. For primary liver cancer, radiotherapy is vital for inoperable patients; however, dosimetric data comparing the rotating gamma ray system (RGS) and volumetric modulated arc therapy (VMAT) remains scarce, complicating clinical technique selection. Notably, RGS refers to a body gamma ray platform designed for extracranial stereotactic body radiotherapy (SBRT) - this is distinct from the "Gamma Knife" system, which is specifically dedicated to intracranial radiosurgery. PURPOSE: To compare the dosimetric differences between RGS and VMAT techniques in the radiotherapy of primary liver cancer.

methods30 patients with primary liver cancer, underwent both RGS and VMAT planning. Analyzed planning target volume (PTV) parameters: coverage (Target Coverage Index, TCI), max/mean/min dose (D

resultsIn this dosimetric comparison of 30 primary liver cancer patients, RGS plans demonstrated significantly higher maximum tumor dose (D

conclusionsIn radiotherapy for primary liver cancer, the rotating gamma ray system offers the characteristic of highly focused central dose with rapid peripheral dose fall-off, ensuring high tumor dose while better protecting adjacent liver tissues. VMAT provides superior conformity and homogeneity, with better control of the mean liver dose and low-dose irradiation volumes.

Indexed as

Gamma RaysLiver NeoplasmsRadiosurgeryRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedFemaleHumansMaleOrgans at RiskPrognosisRadiometryRadiotherapy DosageRetrospective StudiesGamma KnifePrimary Liver CancerVMAT

Identifiers

PMID42298802
PMCPMC13269655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.